Top analyst ranks 22 pharma firms based on R&D prowess

Bristol-Myers Squibb tops the list, compiled by analyst Richard Evans.

By Nicole Gray • May 27, 2014

Growing fear of MERS virus increases urgency of researchers

MERS has killed 181 people worldwide, but its appearance in the U.S. this month surprised authorities. Researchers at NovaVax are using a new method to develop vaccines, which could decrease the decade-long timeline and $1 billion cost associated with vaccine development.

By Nicole Gray • May 22, 2014

Roche expands manufacturing capacity as biologics revenues grow

Roche's oncology franchise continues to grow, with rapidly increasing revenues. To keep up with demand, the company is investing more than $1 billion in increasing manufacturing capacity, with the majority of the investment aimed at biologics manufacturing.

By Nicole Gray • May 19, 2014

Abbott seals deal to buy South American pharma company

Abbott is buying CFR Pharmaceuticals in Chile, with the goal of growing its portfolio, capacity and growth rate.

By Nicole Gray • May 19, 2014

Sun Pharma faces another massive drug recall

The company now has recalled three drugs in three months.

By Nicole Gray • May 16, 2014